A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

NCT06632600 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Chagas Disease

Interventions

DRUG: LXE408
DRUG: Placebo
DRUG: Benznidazole

Sponsor

Novartis Pharmaceuticals